This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter ...

DexCom recently reported preliminary fourth-quarter results showing year-over-year revenue growth in both U.S. and ...

DexCom Inc (NASDAQ:DXCM) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. As of the ...

DexCom Inc. (NASDAQ:DXCM) is a medical device company that focuses on the design, development, and commercialization of CGM (continuous glucose monitoring) systems in the US and internationally.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from ...

"When we arrived at the emergency room, they immediately took us back. They called in a careflight for her, and she was sent ...

Global Digital Health Market OverviewThe global digital health market is projected to grow at a strong rate of around 21% over the next five years, driven by rising smartphone penetration, expanding ...

Last year was not a good one for Dexcom ( DXCM +2.51%). The medical device specialist lagged the market, and even with a bit ...

Our extensive research on the Europe Diabetes Care Devices (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, investment o ...

SAN FRANCISCO – Jake Leach, the new CEO of glucose-monitoring company Dexcom, sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss his vision for the company and how AI and ...